Top seven healthcare leadership problems June 09, 2017By Aubrey WestgateAre you making any of these mistakes? Here are the biggest pitfalls healthcare industry leaders say you should avoid.
In this issue
Personalized medicine brings big wins to managed care June 01, 2017By Tracey WalkerA new report reveals how personalized medicine can make patients healthier while lowering costs. Retail clinic pros and cons: Impact on healthcare spending June 08, 2017By Aine CrytsA new RAND analysis of retail clinics finds they could be increasing healthcare costs. Top four approaches to reduce pharmaceutical costs June 11, 2017By Karen AppoldMCOs are fighting back against rising pharmaceutical costs. Here are the top strategies they are embracing. Value-based drug contracting shifts risk to manufacturers June 03, 2017By Mari EdlinValue-based drug contracting between manufacturers and payers is picking up steam—appropriate timing as the healthcare industry moves toward value-based payment and purchasing and away from fee-for-service. Four health systems develop opioid mitigation programs June 10, 2017By Mari EdlinAlternatives to opioids programs emerge as viable tools to mitigate the crisis. Three ways technology is improving pharmacy June 05, 2017By Donna MarburyTechnology advances in pharmacy include innovations that improve medication safety, efficiency, and patient compliance. Multiple myeloma treatment advances: What health execs should know June 04, 2017By Tracey WalkerIt has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future. Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline. Four ways PBMs must change to thrive in the futureThe days of the traditional, channel-focused and largely enshrouded PBM business model have come and gone. Here’s what’s next.